Media Contact
-
Boehringer Ingelheim GmbH
Dr Reinhard Malin
CD Communications
55216 Ingelheim am Rhein
Germany
Press Conferences
European Society of Hypertension
-
14 June 2009
Taking Action: Combating the Cost of Non-Compliance
Using telmisartan in combination to overcome barriers to blood pressure controlMedia event: Exploring the cost of non-compliance in hypertension and presenting new data from the telmisartan + amlodipine combination therapy Venue: Milan, Italy
June 14, 09:00 CESTWebcast on demand: Available now Website: 
Congress Overview
News & Information
Background information for medical media outside the US only
- News Release Background Information
Speakers
Speakers
Background information for medical media outside the US only
Professor Ambrosioni is currently a member of the Scientific Council of European Society of Hypertension. He was Professor of Internal Medicine and Director of the Division of Internal Medicine, Clinica Medica III, Faculty of Medicine at the University of Bologna until 2004. He has authored or co-authored over 600 publications.
Sarah Jarvis is a GP, GP trainer, fellow of the Royal College of General Practitioners and Women’s Health spokesperson for the RCGP. She is a member of the advisory board of the British Journal of Cardiology and the Healthcare Committee of HEART UK.
Professor Mancia is Professor of Medicine and Chairman of the Department of Medicine at the University of Milan-Biocca. He is currently Chairman of the Education Board of the European Society of Hypertension (ESH), as well as Chairman of the World Health Organization (WHO)/ISH Liasion Committee. He has edited several books on hypertension and has published more than 1,000 original paper, reviews and editorials.
Images
Images & Videos
-
'Newsflash' of Webcast
Highlights of key telmisartan news presented at ESH
-
Webcast on Demand
View the telmisartan webcast, in which Prof. Giuseppe Mancia, Prof. Ettore Ambrosioni and Dr Sarah Jarvis explore the cost of non-compliance in hypertension and present new data for the telmisartan + amlodipine combination therapy
-
Telmisartan and Amlodipine – an effective combination
-
The real cost of the wrong treatment
-
Why patients don't take treatment
